Lenovo has partnered with the Instituto do Coração (InCor), the largest cardiology hospital in Latin America, to introduce TRAdA, an innovative platform designed to help identify arrhythmia events. This new tool uses artificial intelligence in a wearable IoT device for real-time heart monitoring.
In Brazil, more than 20 million people are affected by cardiac arrhythmias, which contribute to over 320,000 sudden deaths annually, according to the Sociedade Brasileira de Arritmias Cardíacas (SOBRAC). This highlights the importance of effective monitoring and timely intervention. The TRAdA device is discreet and comfortable, continuously tracking heartbeats and electrical signals. It employs advanced AI algorithms to detect potential arrhythmia events in real time.
During telemonitoring, critical alerts are sent to a monitoring panel, enabling healthcare professionals to quickly assess and respond to patient needs.
TRAdA has undergone rigorous testing at InCor through three clinical development phases involving 253 participants. In the final phase, a proof of concept was conducted with 51 patients recovering from cardiovascular surgery at home. The system successfully identified arrhythmia episodes and generated alerts that facilitated accurate diagnoses and appropriate treatments.
The first 72 hours after hospital discharge are particularly critical for patients, as research indicates this period is vulnerable to complications. Lenovo’s solution aims to provide essential support during this time. Ricardo Bloj, President of Lenovo Brazil, stated, “We see a significant opportunity in Brazil for a more cost-effective and efficient solution for managing arrhythmia risk. We believe this innovative approach will save lives and enhance healthcare resources by reducing costs and improving care quality.”
Lenovo is committed to scientific rigor and technological innovation with a focus on patient-centered care. The company plans to expand TRAdA into new Latin American markets over the next two years, tailoring the system to meet specific demographic and regulatory needs.
Prof. Fabio B. Jatene, VP of InCor and lead researcher on the TRAdA project, emphasized that innovation in healthcare involves not just creating new technologies but also integrating them into patient care.
He noted that quicker diagnosis of arrhythmias allows for early preventive actions, ultimately enhancing patient safety. This partnership with Lenovo aims to foster collaborative innovation in healthcare.
Related topics:
- Tachycardia Vs Arrhythmia: What Is The Difference
- Chargers Coach Jim Harbaugh Misses Game Start Due to Arrhythmia, Returns to Sidelines
- Excessive Alcohol Consumption Linked to Heart Arrhythmias